The opioid crisis in the United States has brought about the rapid need for understanding the optimal role and the advancement of non-opioid forms of pain control. This session will highlight the current challenges surrounding opioids and the role that neuromodulation and innovative technologies may have in providing successful treatment strategies.
Upon completion of this educational activity, participants should be able to:
- Describe the current opioid epidemic.
- Explain the role of neuromodulation in assisting with pain control with the goal of reducing opioid use.
- Discuss the role of neuromodulation in treating severe opioid addiction.
- Identify risk factors for opioid misuse and abuse.
AANS and AMA Taskforce Response to Opioids
Jennifer A. Sweet, MD
Opioids and Neuromodulation: A Viable Tool to Reduce Use and Best Practice Strategies
Salim M. Hayek, MD, PhD
Neuromodulation to Treat Severe Opioid Addiction: Reality or Fantasy
Ali R. Rezai, MD
Keynote Speaker—Dreamland: America's Opiate Epidemic and How We Got Here
Faculty subject to change.
- Thematic Abstract Presentations
- Plenary Session I - Paradigm Shifts in Neuromodulation: Beyond Programming and Frequency
- Plenary Session II - Targeted by Neuromodulation the Sequelae of Brain Injury
- Plenary Session III - Opening Our Vision and Insight to Pain
- Intrathecal Therapy: Current and Future Best Practice